NOVAVAX INC (NVAX) - Price, trends, fundamentals and chart - Passport to Wall Street

NOVAVAX INC (NASDAQ: NVAX)

Overview

current price

$4.15

$4.15

change

-0.04 | -0.95%

-0.04 | -0.95%

Yesterday's Close

4.19

open

4.26

volume

3.00 M

30d. avg volume.

4.12 M

1 day

4.10 - 4.26

52 weeks

3.53 - 11.36

p/e

0.00

beta

1.5865

market cap

0.59 B

dividend yield

0.00%

Industry

-

News and Commentary

Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits The U.S. Food and Drug Administration on Monday approved and authorized updated COVID-19 vaccines by Moderna Inc

Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Sho... In the midst of a seemingly constant hum of summer activity, something from the past is looming large again: COVID-19.What Happened: New data fro...

Novavax's COVID-19 Vaccine Gets Complete Approval From European Commission The European Commission has approved Novavax Inc's (...

Market Update: Stocks Edge Lower Ahead of April CPI Report Stocks edged lower on Tuesday as market participants looked ahead towards key inflation reports due later this week alongside the latest developments on the U.S. debt ceiling dea...

Novavax Eases Uncertainty, Announces Job Cuts, Encouraging Data From COVID/Flu Combo Shot Novavax Inc (NVAX&nbsp...

October 24 Market Summary Global investors on Monday digested new data, policy statements, and earnings reports. In Europe, the MOEX Russia Index rose 0.99%, the British FTSE rose 0.64%, the German DAX cl...

CDC Recommends Novavax COVID Shots as Mix-and-Match Third Dose Booster The U.S. Centers for Disease Control and Prevention (CDC) recommended Novavax

Pfizer, Moderna Seek FDA Authorization for Bivalent COVID Boosters for Younger Americans Younger children may soon be eligible to receive an Omicron-target booster shot later this year, following U.S. Food and Drug Administration (FDA) applications from Pfizer ...

CDC Eases COVID Guidelines for Quarantine, Marking New Phase of Pandemic The U.S. Centers for Disease Control and Prevention (CDC) has recently eased its COVID-19 guidance...

Market Update: Stocks Extend Losses on Micron Warning, Disappointing Earnings Stocks extended losses on Tuesday as investors weighed a batch of disappointing earnings results while they looked ahead to a key inflation report due out Wednesday. The tech-hea...

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more